Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MIF is a common genetic determinant of COVID-19 symptomatic infection and severity.
Shin JJ, Fan W, Par-Young J, Piecychna M, Leng L, Israni-Winger K, Qing H, Gu J, Zhao H, Schulz WL, Unlu S, Kuster J, Young G, Liu J, Ko AI, Baeza Garcia A, Sauler M, Wisnewski AV, Young L, Orduña A, Wang A, Ocskay K, Garcia-Blesa A, Hegyi P, Armstrong ME, Mitchell PD, Bernardo D, Garami A, Kang I, Bucala R. Shin JJ, et al. Among authors: unlu s. QJM. 2023 Mar 27;116(3):205-212. doi: 10.1093/qjmed/hcac234. QJM. 2023. PMID: 36222594 Free PMC article.
Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency.
Kuster JK, Unlu S, Makin TA, Par-Young J, Simonov M, Shafi S, Balanda M, Randolph C, Steele R, Hsu FI, Price C, Kohli-Pamnani A, Borish L, Lawrence MG, Kang I, Shin JJ. Kuster JK, et al. Among authors: unlu s. J Allergy Clin Immunol Pract. 2022 Feb;10(2):633-636.e3. doi: 10.1016/j.jaip.2021.11.030. Epub 2021 Dec 18. J Allergy Clin Immunol Pract. 2022. PMID: 34929372 Free PMC article. No abstract available.
Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency.
Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. Shin JJ, et al. Among authors: unlu s. J Clin Immunol. 2022 Aug;42(6):1137-1150. doi: 10.1007/s10875-022-01296-4. Epub 2022 Jun 17. J Clin Immunol. 2022. PMID: 35713752 Free PMC article.
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.
Kim JW, McKay RR, Radke MR, Zhao S, Taplin ME, Davis NB, Monk P, Appleman LJ, Lara PN Jr, Vaishampayan UN, Zhang J, Paul AK, Bubley G, Van Allen EM, Unlu S, Huang Y, Loda M, Shapiro GI, Glazer PM, LoRusso PM, Ivy SP, Shyr Y, Swisher EM, Petrylak DP. Kim JW, et al. Among authors: unlu s. J Clin Oncol. 2023 Feb 1;41(4):871-880. doi: 10.1200/JCO.21.02947. Epub 2022 Oct 18. J Clin Oncol. 2023. PMID: 36256912 Free PMC article. Clinical Trial.
Letter to Editor- Reply.
Çatma MF, Ünlü S, Ersan Ö, Öztürk A. Çatma MF, et al. Among authors: unlu s. J Orthop Case Rep. 2020 Aug-Sep;10(5):74. doi: 10.13107/jocr.2020.v10.i05.1847. J Orthop Case Rep. 2020. PMID: 33312986 Free PMC article. No abstract available.
219 results